Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AMERICAN BATTERY MATERIALS, INC.American Battery Materials Reports Improved Net Loss of $403,639 for Q1 2025
FS Credit Real Estate Income Trust, Inc.FS Credit Real Estate Income Trust Reports $42.6M Net Income in Q1 2025
Churchill Capital Corp IX/CaymanChurchill Capital Corp IX Reports $2.7 Million Net Income in Q1 2025
FiscalNote Holdings, Inc.FiscalNote Holdings Reports 14.3% Revenue Decline and $4.3 Million Net Loss in Q1 2025
Satellogic Inc.Satellogic Inc. Reports $3.4 Million Revenue and $32.6 Million Net Loss in Q1 2025
authID Inc.authID Inc. Reports Revenue Growth to $296,000 but Posts $4.3 Million Net Loss in Q1 2025
Moleculin Biotech, Inc.Moleculin Biotech Reports $6.4 Million Net Loss in Q1 2025, Seeks Additional Funding
Intellicheck, Inc.Intellicheck Reports 5% Revenue Growth to $4.9 Million in Q1 2025
GEN Restaurant Group, Inc.GEN Restaurant Group Reports 13% Revenue Growth but Faces $1.96 Million Net Loss in Q1 2025
Rani Therapeutics Holdings, Inc.Rani Therapeutics Reports $12.7 Million Net Loss and First Revenue Recognition
Olema Pharmaceuticals, Inc.Olema Pharmaceuticals Reports $30.4 Million Net Loss in Q1 2025, Sees Improvement Year-Over-Year
FRP HOLDINGS, INC.FRP Holdings Reports 31% Increase in Net Income to $1.7 Million in Q1 2025
Spero Therapeutics, Inc.Spero Therapeutics Reports $13.9 Million Net Loss and 37% Revenue Decline in Q1 2025
Iveda Solutions, Inc.Iveda Solutions Reports $1.47 Million Revenue and Narrows Net Loss in Latest Quarter
BIODESIX INCBiodesix Reports $17.96 Million Revenue in Q1 2025, 21% Increase Year-Over-Year
Mobile Infrastructure CorpMobile Infrastructure Corporation Reports Q1 2025 Financial Results with Revenue Decline and Increased Net Loss
Vaxart, Inc.Vaxart Reports 857% Revenue Growth to $20.9 Million, Despite Net Loss of $15.6 Million
AN2 Therapeutics, Inc.AN2 Therapeutics Reports Improved Net Loss of $10.6 Million in Q1 2025
Bicara Therapeutics Inc.Bicara Therapeutics Reports $36.8 Million Net Loss and Increased R&D Expenses in Latest Quarter
Kezar Life Sciences, Inc.Kezar Life Sciences Reports $16.6 Million Net Loss in Q1 2025, Decreases Operating Expenses
Repare Therapeutics Inc.Repare Therapeutics Reports $30M Net Loss and Zero Revenue in Latest Quarter
Electromed, Inc.Electromed Reports 13.1% Revenue Growth to $15.7 Million in Q3 2025
Semler Scientific, Inc.Semler Scientific Reports 44% Revenue Decline and $64.7 Million Net Loss in Q1 2025
Fathom Holdings Inc.Fathom Holdings Reports 32% Revenue Growth to $93.1 Million, Net Loss Improves
A.K.A. BRANDS HOLDING CORP.a.k.a. Brands Reports Q1 2025 Financial Results with Improved Net Loss and Increased Sales